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Peter Waldenberger, MD,a Nadine Bendix, MD,b Johannes Petersen, MD,a Thomas Tauscher, MD,b and
Bernhard Glodny, MD,a Innsbruck, Austria
Objective: Endovascular occlusion of the celiac artery can be performed along with occlusion of a celiac trunk aneurysm or
stenting of a thoracoabdominal aortic aneurysm to prevent a type II endoleak. Because only a few individual cases have
been previously available for study, the aim of this study was to examine the technical details, clinical course, and outcome
of this procedure based on a group of patients.
Methods:This retrospective study included 10 patients who underwent endovascular occlusion of the celiac artery between
1998 and 2006 (female/male 1:4, mean age, 62.5 9.8 years). There were five aneurysms of the celiac artery, two cases
each of thoracoabdominal aortic aneurysms and dissecting thoracoabdominal aortic aneurysms, and one mycotic
pseudoaneurysm of the aorta. The mean follow-up period was 21.4  29.1 months.
Results: The celiac artery was successfully occluded in all cases, along with exclusion of the celiac artery aneurysm or
thoracoabdominal aortic aneurysm, respectively. The pancreaticoduodenal arteries were the main collateral pathways, but
other anastomoses and, especially, vascular variations of the celiac artery and its territory were also significant. In one
patient, abdominal angina was treated by percutaneous angioplasty and stenting of the superior mesenteric artery.
Conclusions: Endovascular occlusion of the celiac artery is both safe and feasible. Some vascular variations may make
occlusion of the celiac trunk impossible. Liver function disorder is a relative contraindication for this procedure. (J Vasc
Surg 2007;46:655-61.)Occlusion of the celiac artery may be necessary for the
treatment of celiac artery aneurysms or for endovascular
therapy of thoracoabdominal aortic aneurysms in the vicin-
ity of the celiac artery. Although there is evidence that
coverage of the celiac artery origin may be safely achieved
by over-stenting without any prearrangements,1 occlusion
of the celiac artery by coil embolization with simultaneous
revascularization by bypass grafting generally is recom-
mended to prevent a type II endoleak.2,3 The vessels of the
proximal celiac axis alone, that is, the celiac artery and
common hepatic artery (CHA) proximal to an open gas-
troduodenal artery, may also be ligated with only a small
risk of ischemia,4,5 provided the portal vein and the supe-
rior mesenteric artery (SMA) are patent and collateral cir-
culation is available.6 However, the option of transarterial
endovascular occlusion of the celiac artery by coil emboli-
zation for a celiac artery aneurysm or thoracoabdominal
aortic aneurysm in the vicinity of the celiac trunk should
also be considered.
Because there are thus far only individual case reports
on endovascular occlusion of the celiac artery, and only a
few patients have had follow-up,1,7,8 the aim of this study
was to examine and present the clinical and technical details
as well as the outcome of this procedure in a patient series.
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Patients. Between 1998 and 2006, 10 patients (2
women, 8 men) underwent endovascular occlusion of the
celiac artery at our institution. Their average age was of
62.5  9.8 years (range, 49 to 79 years).
Table I summarizes the type, location, and extent of the
aneurysms of the patients. All aneurysms met the standards
set by the Society for Vascular Surgery and the Interna-
tional Society for Cardiovascular Surgery. There was one
thoracoabdominal mycotic pseudoaneurysm of the aorta
with a broad proximal but narrow distal landing zone of
only 14 mm. The thoracic stent graft implantation and
occlusion of the celiac trunk was this patient’s last valid
interdisciplinary treatment option. The technical result was
good.
The diagnosis in most patients was made by computed
tomography (CT) for clarification of epigastric pain. Two
of the celiac artery aneurysms were diagnosed during ultra-
sound scans performed for other diseases. Neither of the
latter two patients showed any symptoms from the aneu-
rysm. The patient with the fusiform aneurysm of the CHA
was in a follow-up program after partial pancreas resection
for a cystadenoma.
All patients were treated exclusively by endovascular
means. Indication for therapy was an aneurysm with a
diameter of more than twice the celiac artery, a pseudoan-
eurysm, a dissecting thoracoaortic aneurysm, or a thoraco-
abdominal aortic aneurysm with a diameter of5 cm in the
vicinity of the celiac artery. Before the occlusion of the
celiac artery by thoracic stent grafting, the celiac artery was
coil embolized to prevent a type II endoleak. In one case of
a Stanford type A dissection, the celiac artery showed a
subtotal stenosis of 98% and could therefore not be embo-
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solely by over-stenting (Table II).
Two patients had an underlying malignancy, one of
which, a case of pancreatic carcinoma, was diagnosed dur-
ing a follow-up examination shortly after the procedure. All
patients had multiple comorbidities (Table I).
A thorough discussion of the procedure, in which all
treatment alternatives were presented, was conducted with
all patients, and all patients signed a written consent form
before the procedure. Institutional ethical approval was
waived because the study had no influence on treatment,
and our institutional Ethical Review Board did not require
its approval for this study.
Preinterventional vascular situation. Nine patients
had a complete celiac artery in the form of a gastrohepato-
splenic celiac trunk, and one patient had an incomplete
hepatosplenic celiac trunk. In this patient, the left gastric
artery (LGA) arose as a robust vessel from the aorta imme-
diately to the left of the celiac trunk. An accessory left
hepatic artery (LHA) arose from this LGA that, in addition
to the LHA, also supplied liver segments II and III. Four of
the nine complete celiac trunks showed the classic trifurca-
tion, and four others had the most common variation of an
early branching of the LGA. One patient had a quartering
instead of a trifurcation of the celiac trunk under the direct
branching of a short dorsal pancreatic artery with the same
caliber as the LGA from the celiac trunk. The four branch-
ing types of the trunks represented in our patient group are
shown in Fig 1, A-D.
Endovascular treatment. Endovascular treatment
was done on monoplanar or biplanar angiography units
(Philips Integris V3000 or V5000; Philips Medical Sys-
tems, Best, The Netherlands) after prior therapy planning
based on a digital subtraction angiography (DSA). De-
Table I. Demographics of patients, procedures, and conco
Patient Age
Aneurysm data
Type Location, extent Siz
1 49 Dissecting TAA 4
2 57 Dissecting CA to CHA 1
3 51 Fusifom CA to RHA 2
4 74 Mycotic
pseudoaneurysm
TAA 5
5 62 Dissecting TAA 5
6 71 Nondissecting TAA 7
7 64 True CA 3
8 57 True CA 3
9 61 True CA 2
10 79 Nondissecting TAA 5
CA, Celiac artery; TAA, thoracoabdominal aneurysm; CHA, common hep
disease; SMA, superior mesenteric artery; RHA, right hepatic artery; CRI,
*Letters refer to panels A-D in Fig 1.pending on the position of the aneurysm in the celiacartery, distal or proximal coil embolization was considered
necessary and, if feasible, was performed in an extension as
far as possible. To prevent a type II endoleak before implan-
tation of a stent graft, the celiac artery was coil embolized
up to the root of the first branch, in most cases the LGA,
without occluding this branch. No coil misplacement oc-
curred.
Cobra II, Sidewinder I or II (4F or 5F, Boston Scien-
tific, Fremont, Calif; Cordis Inc, Miami, Fla), H stick (8F,
Cordis), or Burke catheters (6F, Boston Scientific) served
as guiding catheters. A femoral access was usually used, but
transbrachial access may also be useful, depending on the
take-off angle of the celiac artery, and was chosen once.
Various microcatheters (TurboTracker, Fastracker, Taper
16, and Dasher 14, Boston Scientific; ProwlerPlus, Cordis)
were used. Table II lists the various coils and stent grafts
used during the endovascular interventions and for occlud-
ing the celiac artery.
Follow-up. Before and after the interventions, the
following laboratory indicators were assessed to estimate
cell integrity and hepatic cell and elimination function:
lactate dehydrogenase (LDH), glutamate oxalacetate trans-
aminase (GOT), glutamate pyruvate transaminase (GPT),
-glutamyl transpeptidase (-GT), fibrinogen, interna-
tional normalized ratio (INR), bilirubin, and C-reactive
protein (CRP). Lactate was determined to assess a possible
compromise of intestinal perfusion.
A CT follow-up was done immediately after the proce-
dure, after 6 and 12 months, and annually thereafter to
image the implanted aortic prostheses. After embolization
of the celiac artery, angiographies were done every 6
months for the first 18 months and then in longer intervals,
complemented by CT follow-up examinations. The mean
follow-up period was 21.4  29.1 months (median, 9
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Technical results and follow-up. Occlusion of the
celiac artery was successful in all cases, along with the
exclusion of the celiac artery aneurysm or the thoracoab-
dominal aortic aneurysm, respectively. There was no resid-
ual perfusion of a celiac artery aneurysm, and no reperfu-
sion occurred during follow-up. There were no occurrences
Table II. Endovascular intervention, coils, stent grafts, co
complications
Patient Treatment Specification of coils
1 Aortic endoprosthesis (ET) —
2 CA coil embolization (ET) IDC§ 8/20, 10/10,
10/20 (2), 12/10,
12/20 (4)
3 CA coil embolization (ET) DCS‡ 8/20 (3), 8/30,
6/30, 6/15 (2),
8/15, 8/50, 6/50,
10/20
IDC§ 5/15, 6/20, 7/10,
8/10 (2), 9/10,
10/10, 10/20 (2)
4 CA coil embolization, aortic
endoprosthesis (SUT)
IMWCE‡ 4/3 (3),
5/5 (4)
5 CA coil embolization, aortic
endoprosthesis (ET)
IDC§ 8/10, 10/20,
12/20 (2), 14/10,
14/20 (4)
MWCE‡ 8/12 (2),
15/15
6 CA coil embolization, aortic
endoprosthesis (ET)
IDC§ 5/15, /20 (2),
8/20, 10/20 (5),
12/20, 14/20 (4)
7 CA coil embolization (ET) DCS 6/20, 6/25 (3),
6/30, 6/50 (3), 8/
20 (3), 8/25 (3),
8/30 (3), 8/50 2),
10/30 (4),
20/50 (3)
8 CA coil embolization (ET) IDC§ 14/20, 10/20,
8/10 (3), 6/20 (2)
6/10 (2), 5/15 (2)
GDC§ 18/30 3D (2),
14/30
MWCE‡ 10/15 (2),
8/15 (3), 8/12 (2)
5/8 (4)
9 CA coil embolization (ET) IDC§ 8/20 (4), 12/20,
14/20 (2), vein of
Galen coils 20/10 (3)
Macrospher‡ 12 mm (5)
10 CA coil embolization, aortic
endoprosthesis (ET)
Microcoils 8/60,
6/60 (7) (MIT)
IDC§ 8/10
CA, Celiac artery; CHA, common hepatic artery; DCS, detachable coil system
coil (electrolytically detachable coil); IDC, interlocking detachable coil
Embulous (detachable coil); LGA, left gastric artery; SA, splenic artery; SM
*W.L. Gore & Associates, Flagstaff, Ariz.
†Medtronic, Minneapolis, Minn.
‡Cook, Bloomington, Ind.
§Boston Scientific, Natick, Mass.of type II endoleaks from the celiac artery.Collateralization. The pancreaticoduodenal arteries
and the gastroduodenal artery via the SMA were the most
common collateral pathways, followed by the gastric ar-
teries.
There were five special situations:
1. The gastroepiploic artery and the gastroduodenal artery
bolized branches of the CA, and treatment related
Stent graft CA branches
Treatment related
complications
G Thoracic
Endoprosthesis*
37/20, 37/15
Not involved Abdominal pain, followed
by stent PTA of SMA
— Not involved —
lent† TB2222C116T Occlusion of
the LGA
—
lent† TF4040C114T Not involved —
cluder* 34-20-00,
37-10-00
Not involved —
— LGA
occlusion
—
— CHA, LGA
occlusion
—
— CHA, SA
occlusion
—
—
—
— Not involved —
—
lent† TF2828C100 Not involved One coil moved into the
splenic and hepatic
artery, respectively
—
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tion took place through the LGA, accessory LHA to the
LHA, and intrahepatically to the right hepatic artery
(RHA). There was a second collateral pathway by the
middle colic artery to the RHA (Fig 2, A).
2. Collateralization occurred by way of the pancreaticodu-
odenal arteries to the gastroduodenal artery, hepatic
artery proper, and LHA, and in this case continued to
the accessory LHA (Fig 2, B).
3. The accessory LHA provided antegrade collateraliza-
tion because the LGA had remained patent due to early
branching off from the celiac trunk (Fig 2, C).
4. A robust dorsal pancreatic artery formed the anastomo-
sis between the SMA and the celiac artery (Fig 2, D).
5. A very robust anastomosis existed between the right gas-
troepiploic artery and the left gastroepiploic artery,
through which the splenic artery was well contrasted (Fig
2, E).
Plasmatic laboratory indicators. The levels for GOT,
GPT, -GT, and LDH rose slightly immediately postpro-
cedure and returned to normal levels about 1 week later.
These levels were equal for all patients, including the pa-
tient with a secondary adjunctive stent in the SMA. Lactate,
liver synthesis measures, and all other plasmatic laboratory
indicators remained unaffected.
Complications. One patient, who had a mycotic aortic
Fig 1. A-D, The four branching types of the celiac tru
hepatic artery; CA, celiac artery; CHA, common hepatic
LHA, left hepatic artery; SA, splenic artery; RHA, rightaneurysm, died of a myocardial infarction 2 days after theprocedure. By convention, this major complication must be
considered directly related to the procedure. Two minor com-
plications were related to the occlusion of the celiac trunk:
1. This patient had a subtotal (98%) stenosis of the celiac
trunk. Abdominal pain developed 2 days after the inter-
vention, and a CT showed bowel loops that were
slightly thick-walled. The subsequent angiography of
the SMA showed that a stent strut of the lower edge of
the Gore aortic prosthesis was partially covering the
branching of the SMA, causing a functional decrease in
perfusion. After a stent PTA of the ostium, the patient
was free of pain.
2. In this patient, the coils in the splenic artery and hepatic
artery became displaced distal to the initial placement
site without leading to thromboembolic complications.
This was a technical complication that was not treated
and had no sequelae.
A type I endoleak developed at the distal end of the aortic
prosthesis in a patient with pancreas cancer. The endoleak was
monitored for 8 months, until the patient died of cancer.
The complications of the procedures are also listed in Table II.
DISCUSSION
This study shows that therapeutic endovascular occlu-
sion of the celiac artery can be performed without leading
epresented in the patient group. ALHA, Accessory left
y; GDA, gastroduodenal artery; LGA, left gastric artery;
tic artery; SMA, superior mesenteric artery.nks r
arterto clinically significant ischemia of the upper abdominal
, spl
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and morbidity was also 10%. The patient who died of a
myocardial infarction after the procedure had an infectious
aortic aneurysm, had multiple morbidities, and had a poor
prognosis. The stent graft implantation and occlusion of
the celiac trunk, despite unstable angina pectoris, was her
last valid interdisciplinary therapy option and the tech-
nical result was very good. One patient’s abdominal
Fig 2. A-E, The five special collateral pathways represen
CA, celiac artery; CHA, common hepatic artery; DPA,
hepatic artery proper; IPA, inferior pancreatic artery; LG
left hepatic artery; MCA, middle colic artery; RGA, righ
right gastroepiploic artery; RHA, right hepatic artery; SAangina, which resulted from the partial blockage of theSMA by the aortic prosthesis, was successfully treated by
PTA and stenting.
One limitation of our study is the relatively small group
of 10 patients. The reason for this is that aneurysms of the
celiac artery are rare, and paraceliac aortic aneurysms re-
quiring endovascular over-stenting of the celiac trunk are
not as frequent as more proximal aneurysms. Many patients
with celiac trunk or aortic aneurysms have multiple comor-
the patient group. ALHA, Accessory left hepatic artery;
l pancreatic artery; GDA, gastroduodenal artery; HAP,
ft gastric artery; LGEA, left gastroepiploic artery; LHA,
tric artery; PDA, pancreaticoduodenal arteries; RGEA,
enic artery; SMA, superior mesenteric artery.ted in
dorsa
A, le
t gasbidities, as in our study, and for most of them, the risk of
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operation of the celiac artery9 or even higher for aorta
replacement surgery. Thus, endovascular therapy can be an
appealing alternative to open surgery in selected cases.
Although treatment is generally recommended for an-
eurysms of the visceral arteries with a ratio of the aneurysm
diameter to the parent vessel 2,8 in this study even
relatively small aneurysms of the celiac trunk with a ratio of
2.2 to the parent vessel were treated. The rationale behind
this is that acute therapy for a visceral artery aneurysm
results in much higher mortality than elective endovascular
treatment.10 The prognosis after the rupture of a celiac
trunk aneurysm is generally poor.11 In view of these facts,
we recommend early preventive treatment.
Before endovascular therapy for paravisceral thoracoab-
dominal aortic aneurysms, occlusion of the celiac artery had
been generally accepted for prevention of a type II endoleak
if the level of the celiac artery was needed as distal landing
zone.2,3 However, some evidence indicates that this proce-
dure might be unnecessary in most cases.1 At the present
time, no reliable data are available on which patients would
or would not benefit from ligation or embolization of the
celiac artery before the implantation of the thoracic stent
graft.
Influencing factors may be the configuration of the
aorta and the diameter and position of the celiac artery and
the SMA, as well as the length of the celiac artery. Collat-
eralization from the splenic to the hepatic artery, and vice
versa, might be impaired by embolization material, espe-
cially when the celiac artery is short, although we did not
observe such a situation. Although type II endoleaks do not
seem to occur even without prior embolization,1 type I
endoleaks may possibly evolve from incomplete over-stenting
of the celiac artery as well. Further investigations of this
point are needed, however.
In all 10 patients, the anatomic vascular situation was
unproblematic or even favorable for occluding the celiac
trunk. Only one patient presented with abdominal angina
and functional underperfusion of the SMA. The immediate
disappearance of these symptoms after PTA and stenting of
the SMA branch confirmed that functional restriction of
blood flow was a result of the blockage of the vascular
branch by a stent strut of the aortic prosthesis. In this case,
the replaced RHA from the SMA ensured the blood supply
to the right liver segments.
In general however, occlusion of the celiac trunk
should be avoided if the portal vein or the SMA are not
patent6 or in case of a liver function disorder. Occlusion of
the gastroduodenal artery also presents a relative contrain-
dication. Incomplete celiac trunks with single branches of
all vessels from the aorta, which are very rare—less than 1%
of all cases12—as well as celiac trunk variations in the form
of celiac trunks including the superior mesenteric artery,
should be classified as very problematic. These include
configurations such as a gastrohepatosplenomesenteric ce-
liac trunk, which occurs in 2.4% of cases,13 a hepatosple-
nomesenteric celiac trunk, which occurs in 1.2%,13 and a
hepatomesenteric celiac trunk, which occurs in up to 3%.12For the latter, it must be taken into consideration that
neither a common origin nor a direct connection exists
between the splenic and the hepatic artery.
Numerous ways of collateralizing the arterial territories
of the spleen, liver, and pancreas have been reported. The
pancreatic arcades are the most important ones used when
the celiac trunk is ligated.14 In addition, the transverse
pancreatic artery, small intrapancreatic arteries, and the
dorsal pancreatic artery14 are potential pathways. In case of
an incomplete celiac trunk, the intraceliac collaterals by way
of the gastroepiploic and the gastric arteries can be signifi-
cant.14 The connections between the vascular territory of
the RHA and LHA are important as regular intraceliac
collaterals.15
Renal-celiac collaterals can become symptomatic as a
renal-splanchnic steal and arterial hypertension if they are
done at the expense of the renal supply, although to our
knowledge this has never been described after artificial
occlusion of the celiac artery. These are anastomoses in-
volving the inferior phrenic or inferior adrenal arteries and
are connected with branches of either the splenic or the
hepatic artery.14
There are also connections from the celiac territory to
the 12th intercostal artery, to the middle suprarenal artery
from the aorta,16 and to the superior lumbar arteries.17 The
superior suprarenal arteries from the inferior phrenic artery
can also supply the celiac territory.18 The Arc of Bühler is a
remnant of the embryonic vertical connection between the
superior mesenteric artery and the celiac trunk and is re-
garded as an atypical collateral, as are potential connections
to the middle colic artery.19
In nine of 10 of our patients, robust pancreatic arcades
were observed before the procedure that ensured blood sup-
ply to the celiac artery territory. In the remaining case, the
classic pathway by way of the pancreaticoduodenal arteries was
occluded because the gastroduodenal artery had been clipped.
This patient had a favorable constellation of an incomplete
celiac trunk with collateralization occurring through the ac-
cessory LHA to the LHA, as well as atypical collaterals
through the middle colic artery from the SMA. Aside from
these, pathways from the gastroepiploic artery and the dorsal
pancreatic artery were each seen once, but not, however, in
any of the other paths described above.
The release of -GT, alanine aminotransferase, aspar-
tate aminotransferase, and LDH indicates that the celiac
trunk occlusion causes slight acute hepatic cell decay.20 It is
only of short duration and, owing to its slight extent,
appears to have no clinical relevance for patients with
healthy livers. Although an effect on the liver synthesis
parameters could not be proven from the slight cell decay
found, it must be assumed that at times a slight reduction
occurs in liver synthesis performance. The temporary im-
pairment of the liver from occlusion of the celiac trunk was
shown here for the first time, to our knowledge. This
impairment must be taken into consideration for patients
with existing liver function disorders.
Recent reports of individual cases of endovascular occlu-
sion of the celiac trunk, either to treat a celiac trunk aneu-
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nal aortic aneurysm,22 prove the feasibility of endovascular
therapy for these two indications. The results from this initial
series of patients are encouraging. The treatment was techni-
cally successful for all patients, and the morbidity of the
procedure was low. It should be noted, however, that occlu-
sion of the celiac trunk could be impossible for some patients
owing to complex vascular variations. Therefore, a treatment
concept must be created for the individual anatomic situation
in each patient before the intervention. Liver function disor-
ders are a relative contraindication.
CONCLUSION
Occlusion of the celiac artery by coil embolization for
treatment of a celiac trunk aneurysm or for stent graft
implantation to treat a thoracoabdominal aortic aneurysm
is feasible, with a low risk of ischemia. Numerous collater-
als, especially the gastric and pancreaticoduodenal arteries,
ensure the supply of the celiac artery territory. Celiac
trunks, including the SMA, incomplete celiac trunks, or
occlusion of the gastroduodenal artery are relative contra-
indications. The existence of sufficient collateralization
must be established by angiography before the procedure.
We are indebted to Julia Mahlknecht for painting the
diagrams and Ingrid Messirek for her help with further
processing.
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